Immediate Impact
59 standout
Citing Papers
The oral–gut microbiome axis in health and disease
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Sarah Fitzpatrick being referenced
A phase 1/2 study of the highly selective EGFR inhibitor, BLU-701, in patients with EGFR-mutant non–small cell lung cancer (NSCLC).
2022
The association between periodontal disease and cancer: A review of the literature
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sarah Fitzpatrick | 353 | 230 | 556 | 64 | 970 | |
| John A. Svirsky | 458 | 224 | 424 | 31 | 948 | |
| E Bucci | 328 | 224 | 500 | 39 | 1.1k | |
| Ying‐Shiung Kuo | 349 | 220 | 421 | 47 | 1.1k | |
| Stanley M. Kerpel | 381 | 190 | 361 | 27 | 852 | |
| Mark Schifter | 271 | 210 | 579 | 30 | 884 | |
| R Küffer | 214 | 235 | 355 | 61 | 931 | |
| Leticia Bagán | 304 | 136 | 381 | 58 | 1.1k | |
| George E. Kaugars | 724 | 239 | 235 | 40 | 1.1k | |
| Ajit Auluck | 164 | 186 | 260 | 35 | 838 | |
| Bengt Hasséus | 271 | 109 | 322 | 64 | 1.0k |
All Works
Loading papers...